Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Identify Predictors of Response to Duloxetine in Breast Cancer Patients With Chronic Pain

NCT01912612 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.

NCT NCT01912612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01912612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Identify Predictors of Response to Duloxetine in Breast Cancer Patients With Chronic Pain
Lead sponsor
University of Michigan Rogel Cancer Center
Phase
Phase 2
Overall status
Completed
Start date
October 30, 2013
Completion date
June 28, 2019
Enrollment
82 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pain